Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sucampo Pharmaceuticals SCMP

Healthcare Drug Manufacturers - Specialty & Generic
"Sucampo Pharmaceuticals Inc is a part of the healthcare sector in the United States. As a global pharmaceutical company, it commercializes drugs for the treatment of various gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It currently generates revenue mainly from product royalties, product sales, upfront and milestone payments, and reimbursements for development... see more

Recent & Breaking News (NDAQ:SCMP)

Investor Network: Sucampo Pharmaceuticals, Inc. to Host Earnings Call

Accesswire May 3, 2017

Sucampo Reports First Quarter 2017 Financial Results

GlobeNewswire May 3, 2017

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Deutsche Bank 42nd Annual Health Care Conference

GlobeNewswire April 26, 2017

New Study Published in PLOS ONE Advances Science Around VTS-270 for Treatment of Niemann-Pick Disease Type C1

GlobeNewswire April 18, 2017

Drug Makers Stocks Under Scanner -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma

PR Newswire April 5, 2017

Sucampo Acquires Vtesse Inc.

GlobeNewswire April 3, 2017

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 16th Annual Needham Healthcare Conference

GlobeNewswire March 28, 2017

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference

GlobeNewswire March 15, 2017

Mid-Morning Market Update: Markets Edge Higher; Staples Earnings Miss Views

Benzinga.com  March 9, 2017

Mid-Afternoon Market Update: Dow Falls 50 Points; H & R Block Shares Spike Higher

Benzinga.com  March 8, 2017

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  March 8, 2017

Mid-Day Market Update: Crude Oil Down Over 3%; Express Shares Drop On Weak Forecast

Benzinga.com  March 8, 2017

22 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  March 8, 2017

Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results

GlobeNewswire March 8, 2017

How These Healthcare Stocks are Faring? -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma

PR Newswire March 1, 2017

Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call

GlobeNewswire February 23, 2017

Sucampo Pharmaceuticals Set to Join S&P SmallCap 600

PR Newswire February 17, 2017

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference

GlobeNewswire February 9, 2017

Drug Makers Stocks on Investors' Radar -- Synergy Pharma, Novo Nordisk, Sucampo Pharma, and Pernix Therapeutics

PR Newswire January 20, 2017

Mid-Morning Market Update: Markets Open Lower; Morgan Stanley Tops Q4 Estimates

Benzinga.com  January 17, 2017